Research ArticleCancer

Postsurgical adjuvant or metastatic renal cell carcinoma therapy models reveal potent antitumor activity of metronomic oral topotecan with pazopanib

See allHide authors and affiliations

Science Translational Medicine  08 Apr 2015:
Vol. 7, Issue 282, pp. 282ra50
DOI: 10.1126/scitranslmed.3010722

Log in to view Figures & Data

Log in through your institution

Log in through your institution

Stay Connected to Science Translational Medicine